Germany says production capacity, not patents, key to upping vaccine output

over 4 years in nationalpost

BERLIN — The main challenge to raising production of COVID-19 vaccines is how to quickly and effectively transfer technology, Germany’s health minister said Friday, reiterating Berlin’s opposition to a U.S. proposal to waive patent protection. “The main issue is not patent protection but production capacity,” Jens Spahn told a news conference on Friday. In a […]

Mentioned in this news
Share it on